EXTON, PA -- (Marketwired) -- 07/30/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second quarter of 2015 and updated financial guidance for the full year 2015.
Executive Summary
Reported sales of $359.7 million declined 2.5% vs. 2014 period. Net sales at constant currency grew by 7.4%. Reported diluted EPS was $0.38. Adjusted diluted EPS was $0.47, excluding a $0.09 charge on executive retirement.
EPS comparisons to the prior-year period are adversely impacted by approximately $0.09 of currency effects.
Full-year adjusted diluted EPS is anticipated to be between $1.74 and $1.84, reflecting a $0.05 increase to the lower-end of the range of previous guidance.
Raises base of constant currency revenue growth guidance, to 7% to 8% for the year.
Recently announced the 23rd consecutive annual increase in the dividend, to $0.12 per share in the fourth quarter 2015.
Help employers find you! Check out all the jobs and post your resume.
